FRANCE – Sanofi has announced the acquisition of Origimm Biotechnology, an Austrian privately held biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing…
Read MoreTag: Austria
Hyloris announces approval of novel drug for post-operation pain management
BELGIUM – Hyloris Pharmaceuticals SA, a specialty biopharmaceutical company dedicated to addressing unmet medical needs by reinventing existing medications, has announced the expansion of the European footprint of Maxigesic IV…
Read MoreBoehringer launches state-of-the-art biopharma production facility in Vienna
GERMANY – German family-owned biopharma major Boehringer Ingelheim has inaugurated a state-of-the-art biologics facility in Vienna, Austria heralding the single-largest investment in the company’s history. The Large-Scale Cell Culture (LSCC)…
Read More